New York S 9279: Provides for the enrollment of certain persons in direct deposit for compensation payments

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S09279 Summary:

BILL NOS09279A

&nbsp

SAME ASSAME AS A03283-C

&nbsp

SPONSORGIANARIS

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Add Art 32-B §3230, Pub Health L

&nbsp

Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.

Go to top S09279 Actions:

BILL NOS09279A

&nbsp

02/24/2026REFERRED TO HEALTH

03/13/2026AMEND AND RECOMMIT TO HEALTH

03/13/2026PRINT NUMBER 9279A

05/19/20261ST REPORT CAL.1239

05/20/20262ND REPORT CAL.

05/21/2026ADVANCED TO THIRD READING 

06/02/2026SUBSTITUTED BY A3283C

&nbspA03283 AMEND=C Bores

&nbsp01/27/2025referred to health

&nbsp03/12/2025amend (t) and recommit to health

&nbsp03/12/2025print number 3283a

&nbsp01/07/2026referred to health

&nbsp02/23/2026amend and recommit to health

&nbsp02/23/2026print number 3283b

&nbsp03/12/2026amend and recommit to health

&nbsp03/12/2026print number 3283c

&nbsp03/17/2026reported 

&nbsp03/19/2026advanced to third reading cal.315

&nbsp03/23/2026passed assembly

&nbsp03/23/2026delivered to senate

&nbsp03/23/2026REFERRED TO HEALTH

&nbsp06/02/2026SUBSTITUTED FOR S9279A

&nbsp06/02/20263RD READING CAL.1239

&nbsp06/02/2026PASSED SENATE

&nbsp06/02/2026RETURNED TO ASSEMBLY

Go to topS09279 Committee&nbspVotes:

Go to topS09279 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS09279 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 9279--A

 IN SENATE

 February 24, 2026
 ___________

 Introduced by Sen. GIANARIS -- read twice and ordered printed, and when
 printed to be committed to the Committee on Health -- committee
 discharged, bill amended, ordered reprinted as amended and recommitted
 to said committee

 AN ACT to amend the public health law, in relation to the operation of
 gene synthesis providers and manufacturers of gene synthesis equipment

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Short title. This act shall be known and may be cited as
 2 the "bioterrorism prevention act".
 3 § 2. The public health law is amended by adding a new article 32-B to
 4 read as follows:
 5 ARTICLE 32-B
 6 GENE SYNTHESIS LABS
 7 Section 3230. Operation of gene synthesis providers and manufacturers of
 8 gene synthesis equipment.
 9 § 3230. Operation of gene synthesis providers and manufacturers of
 10 gene synthesis equipment. Any gene synthesis provider or manufacturer
 11 of laboratory equipment intended for use by a gene synthesis provider
 12 shall operate in accordance with rules and regulations issued by the
 13 department, including regulations on identifying potentially dangerous
 14 genetic sequences, screening potential customers and retaining records
 15 of genes synthesized and/or delivered. The department shall utilize
 16 generally accepted industry standards and take into consideration recom-
 17 mendations and protocols set by the international gene synthesis consor-
 18 tium and/or other similar nationally or internationally recognized rele-
 19 vant organizations to draft such rules and regulations. For the purpose
 20 of this section, "gene synthesis provider" shall mean any entity that
 21 synthesizes and distributes synthetic nucleic acids to a customer or to
 22 a distributor.
 23 § 3. This act shall take effect on the ninetieth day after it shall
 24 have become a law.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD04229-07-6

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps